Monomethacryloxypropyl terminated polydimethylsiloxanes - asymmetric 6-9cSt, 100g

Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-lambda5-phosphane, 98+%, 1g

2-trifluoromethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol, 95.0%, 5g

1-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate, 98.0%, 250mg

5-methyl-2-(methylsulfanyl)-1H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one, 99.95%, 10g

4-Amino-3,3-dimethylbutanoic acid hydrochloride, 95%, 5g

Alcyne-dATP, ≥95%, 100 µl, emballage plastique.

3-CHLORO-2-FLUORO-5-TRIFLUOROMETHYLBENZONITRILE, 95.0%, 100mg

3-((3-methylphenyl)sulfonamido)propanoic acid, 95.0%, 1g

5-Fluoro-2-iodo-4-(trifluoromethyl)aniline, 98%, 1g

cis-2,6-Dimethylmorpholine, 97.0%, 100g

4-allyl-5-(2-phenylethyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 1g